Sumant Kulkarni

Canaccord Genuity | Healthcare

Sumant Kulkarni is an analyst from Canaccord Genuity specializing in the Healthcare sector. Ranked #314 out of 4773 analysts, they have issued 36 stock ratings with a success rate of 81.06% and an average return of 51.44%.

Sumant Kulkarni has a well-established track record, with 36 ratings issued in the Healthcare sector. They have consistently delivered a success rate of 81.06% and an average return of 51.44%, underscoring their expertise and ability to identify winning opportunities for investors.

#314

Out of 4773

36

Total Ratings

+81.06%

Success Rate

+51.44%

Average Return

Recent Ratings Analysis

ANVS

Aug 18, 2026

Target

$17.00

Current

$1.12

Performance

-37.78%

Sumant Kulkarni rated ANVS as Buy on Aug 18, 2026, setting a price target of 17. The stock has underperformed, dropping 37.78% despite the bullish target of 17.

STOK

Aug 04, 2026

Target

$58.00

Current

$29.03

Performance

-8.34%

On Aug 04, 2026, STOK was given a Buy rating by Sumant Kulkarni, with a target price of 58. Despite the Buy call, shares fell from 29.03 to 29.03, challenging the optimistic stance.

NBIX

Aug 03, 2026

Target

$210.00

Current

$156.22

Performance

-6.02%

NBIX received a Buy rating from Sumant Kulkarni on Aug 03, 2026, aiming for 210. The rating hasn’t played out as hoped, with the stock trading 6.02% below expectations.

BIIB

Jul 30, 2026

Target

$248.00

Current

$217.15

Performance

4.43%

On Jul 30, 2026, Sumant Kulkarni published a Buy outlook on BIIB, with a target of 248. So far, the stock has neither confirmed nor rejected the Buy case, holding within range of 217.15.

MPLT

Jul 28, 2026

Target

$24.00

Current

$13.00

Performance

5.61%

Sumant Kulkarni on Jul 28, 2026 assigned MPLT a Buy rating, with a price target of 24. The Buy call aligned well with market performance, producing a gain of 5.61%.

ZVRA

Jul 27, 2026

Target

$20.00

Current

$12.01

Performance

23.69%

On Jul 27, 2026, Sumant Kulkarni reaffirmed ZVRA with a Buy rating, targeting 20. The recommendation was supported by strong follow-through as the stock rose from 12.01 to 12.01.

ATAI

Jul 16, 2026

Target

$8.00

Current

$7.35

Performance

2.80%

ATAI was rated Hold by Sumant Kulkarni on Jul 16, 2026, with a price objective of 8. Flat performance suggests the Hold view was reasonable.

HELP

Jul 01, 2026

Target

$42.00

Current

$12.97

Performance

106.53%

On Jul 01, 2026, Sumant Kulkarni initiated coverage on HELP with a Buy rating and target of 42. The stock’s climb of 106.53% since the call highlights the foresight in the rating.

DFTX

Jun 30, 2026

Target

$58.00

Current

$38.89

Performance

-17.33%

Sumant Kulkarni issued a Buy recommendation for DFTX on Jun 30, 2026, price target set at 58. The market hasn’t rewarded the bullish outlook, exposing uncertainty in the call.

ACAD

Jun 29, 2026

Target

$36.00

Current

$27.83

Performance

10.44%

On Jun 29, 2026, ACAD was evaluated by Sumant Kulkarni, who gave a Buy rating and target of 36. This case illustrates how a timely bullish rating can translate into tangible gains of 10.44%.

CMPS

Jun 26, 2026

Target

$20.00

Current

$14.35

Performance

-3.17%

Sumant Kulkarni rated CMPS as Buy on Jun 26, 2026, setting a price target of 20. Shares have remained stable near 14.35, leaving the 20 target still in play.

CLNN

Mar 13, 2026

Target

$48.00

Current

$3.57

Performance

-37.59%

On Mar 13, 2026, CLNN was given a Buy rating by Sumant Kulkarni, with a target price of 48. Despite the Buy call, shares fell from 3.57 to 3.57, challenging the optimistic stance.

GHRS

Jan 06, 2026

Target

$39.00

Current

$27.20

Performance

92.63%

GHRS received a Buy rating from Sumant Kulkarni on Jan 06, 2026, aiming for 39. Momentum has favored the Buy call, with shares climbing from 27.2 to 27.2, rewarding those who trusted the recommendation.

CYBN

Nov 20, 2025

Target

$45.00

Current

$8.28

Performance

41.54%

On Nov 20, 2025, Sumant Kulkarni published a Buy outlook on CYBN, with a target of 45. Shares gained 41.54%, underscoring the accuracy of the bullish outlook toward 45.

MNMD

Nov 07, 2025

Target

$25.00

Current

$20.69

Performance

76.84%

Sumant Kulkarni on Nov 07, 2025 assigned MNMD a Buy rating, with a price target of 25. The Buy call aligned well with market performance, producing a gain of 76.84%.

CRVO

Jul 29, 2025

Target

$27.00

Current

$2.57

Performance

-69.48%

On Jul 29, 2025, Sumant Kulkarni reaffirmed CRVO with a Buy rating, targeting 27. Shares slid 69.48% despite the recommendation, highlighting downside risks.

SAGE

Jun 17, 2025

Target

$8.50

Current

$8.68

Performance

-4.82%

SAGE was rated Hold by Sumant Kulkarni on Jun 17, 2025, with a price objective of 8.5. Flat performance suggests the Hold view was reasonable.

VYGR

Mar 13, 2025

Target

$12.00

Current

$3.19

Performance

-21.62%

On Mar 13, 2025, Sumant Kulkarni initiated coverage on VYGR with a Buy rating and target of 12. The Buy call has yet to be validated as shares remain 8.81 away from the target.

ITCI

Jan 31, 2025

Target

$132.00

Current

$131.87

Performance

3.77%

Sumant Kulkarni issued a Hold recommendation for ITCI on Jan 31, 2025, price target set at 132. The rating was appropriate for a consolidating market trading near 131.87.

BTAI

Jan 06, 2025

Target

$5.00

Current

$0.07

Performance

-99.19%

On Jan 06, 2025, BTAI was evaluated by Sumant Kulkarni, who gave a Buy rating and target of 5. Investors saw limited payoff as shares fell short of the 5 target.

Frequency Asked Questions

Who is Sumant Kulkarni?

Sumant Kulkarni is an analyst from Canaccord Genuity specializing in the Healthcare sector.

What is Sumant Kulkarni's success rate?

Sumant Kulkarni currently has a success rate of +81.06%.

How many ratings has Sumant Kulkarni issued?

Sumant Kulkarni has issued 36 stock ratings so far.

What is the average return of Sumant Kulkarni's calls?

Their stock ratings have generated an average return of +51.44%.

What is Sumant Kulkarni's ranking?

Sumant Kulkarni is ranked #314 out of 4773 analysts.

What types of ratings does Sumant Kulkarni give?

Their ratings include Buy, Hold, and Sell recommendations, depending on the stock’s outlook.

How can I follow Sumant Kulkarni?

You can follow Sumant Kulkarni by clicking the "Follow Analyst" button on this page to receive updates on their stock calls.

What is the most recent rating by Sumant Kulkarni?

Their latest rating was a Buy on ANVS issued on 2026-08-18.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep